High Resolution MRI in the Evaluation of Laryngeal Neoplasia
N/A
18 Years
N/A
18 Years
N/A
Not Enrolling
Both
Laryngeal Neoplasms, Head and Neck Cancers, Larynx Cancer
Both
Laryngeal Neoplasms, Head and Neck Cancers, Larynx Cancer
Trial Information
High Resolution MRI in the Evaluation of Laryngeal Neoplasia
Inclusion Criteria:
- Patients with benign or malignant neoplasm of the larynx.
- Patients who have undergone prior surgery, radiation therapy, or chemotherapy for
cancer of the laryngopharynx will be eligible to participate.
- Patients 18 years of age and older at time of evaluation, male and female, all
ethnicities.
- Ability to understand and the willingness to sign a written informed consent
document.
Exclusion Criteria:
- Pregnancy
- Claustrophobia.
- Anatomic parameters which preclude scanning, such as limited range of neck motion, or
inability to remain flat for at least 15 minutes.
- Patients with implanted devices (eg, defibrillator, pacemaker) that are a known
contraindication to magnetic resonance imaging.
- Allergy to gadolinium contrast.
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Outcome Measure:
Tumor stage as determined by histopathology in excised larynges.
Outcome Time Frame:
4 to 6 weeks
Safety Issue:
No
Principal Investigator
Edward J. Damrose MD, FACS
Investigator Role:
Principal Investigator
Investigator Affiliation:
Stanford University
Authority:
United States: Institutional Review Board
Study ID:
ENT0019
NCT ID:
NCT00965003
Start Date:
July 2009
Completion Date:
July 2014
Related Keywords:
- Laryngeal Neoplasms
- Head and Neck Cancers
- Larynx Cancer
- Neoplasms
- Laryngeal Neoplasms
- Head and Neck Neoplasms
- Laryngeal Diseases
Name | Location |
|---|---|
| Stanford University School of Medicine | Stanford, California 94305-5317 |
